29 related articles for article (PubMed ID: 16494624)
1. Secondary acute promyelocytic leukemia following chemotherapy for gastric cancer: a case report.
Zhang YC; Zhou YQ; Yan B; Shi J; Xiu LJ; Sun YW; Liu X; Qin ZF; Wei PK; Li YJ
World J Gastroenterol; 2015 Apr; 21(14):4402-7. PubMed ID: 25892894
[TBL] [Abstract][Full Text] [Related]
2. Combination Chemotherapy of Azacitidine and Cetuximab for Therapy-Related Acute Myeloid Leukemia following Oxaliplatin for Metastatic Colorectal Cancer.
Hashimoto A; Takada K; Horiguchi H; Sato T; Iyama S; Murase K; Kamihara Y; Ono K; Tatekoshi A; Hayashi T; Miyanishi K; Sato Y; Furuhata T; Kobune M; Takimoto R; Hirata K; Kato J
Case Rep Oncol; 2014 May; 7(2):316-22. PubMed ID: 24932174
[TBL] [Abstract][Full Text] [Related]
3. Chronic myeloid leukemia following colon cancer treatment: A case report and literature review.
Vakili-Sadeghi M; Omranpour M
Caspian J Intern Med; 2013; 4(3):739-42. PubMed ID: 24009972
[TBL] [Abstract][Full Text] [Related]
4. Chronic myeloid leukemia following the treatment of rectal adenocarcinoma.
Kadikoylu G; Yavasoglu I; Barutca S; Meydan N; Bolaman Z
Med Oncol; 2008; 25(4):467-70. PubMed ID: 18373227
[TBL] [Abstract][Full Text] [Related]
5. Sequential mutations causing resistance to both Imatinib Mesylate and Dasatinib in a chronic myeloid leukaemia patient progressing to lymphoid blast crisis.
Stagno F; Stella S; Berretta S; Massimino M; Antolino A; Giustolisi R; Messina A; Di Raimondo F; Vigneri P
Leuk Res; 2008 Apr; 32(4):673-4. PubMed ID: 17889935
[No Abstract] [Full Text] [Related]
6. The era of personalized medicine: back to basics.
Hutchinson L; DeVita VT
Nat Clin Pract Oncol; 2008 Nov; 5(11):623. PubMed ID: 18957968
[No Abstract] [Full Text] [Related]
7. Chronic myeloid leukemia presenting with extramedullary disease as massive ascites responding to imatinib mesylate.
Aleem A; Siddiqui N
Leuk Lymphoma; 2005 Jul; 46(7):1097-9. PubMed ID: 16019565
[TBL] [Abstract][Full Text] [Related]
8. Imatinib induces a cytogenetic response in blast crisis or interferon failure chronic myeloid leukemia patients with e19a2 BCR-ABL transcripts.
Lee JJ; Kim HJ; Kim YJ; Lee S; Hwang JY; Kim YL; Kim DW
Leukemia; 2004 Sep; 18(9):1539-40. PubMed ID: 15284852
[No Abstract] [Full Text] [Related]
9. Bcr-abl positive blast crisis of chronic myeloid leukemia emerging in a case of metastatic colorectal cancer 3 months after completion of an 8-month course of cetuximab and irinotecan.
Buxhofer-Ausch V; Hinterberger-Fischer M; Hinterberger W
Eur J Haematol; 2006 May; 76(5):447-8. PubMed ID: 16494624
[No Abstract] [Full Text] [Related]
10. [Research advance on molecular genetics of CML blast crisis].
Zhu HQ; Zhang S; Liu XL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Feb; 16(1):217-21. PubMed ID: 18315935
[TBL] [Abstract][Full Text] [Related]
11. [Development of Ph negative acute myeloid leukemia in a patient with minor-BCR/ABL positive chronic myeloid leukemia achieving a partial cytogenetic response during tyrosine kinase inhibitor treatment].
Fujii S; Miura I; Tanaka H
Rinsho Ketsueki; 2015 Jun; 56(6):681-6. PubMed ID: 26256879
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
